SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-13-005739
Filing Date
2013-12-10
Accepted
2013-12-10 16:46:33
Documents
11
Period of Report
2013-10-31

Document Format Files

Seq Description Document Type Size
1 c75814_10q.htm 10-Q 477081
2 c75814_ex31-1.htm EX-31.1 9016
3 c75814_ex31-2.htm EX-31.2 9004
4 c75814_ex32-1.htm EX-32.1 3373
5 c75814_ex32-2.htm EX-32.2 3057
  Complete submission text file 0000930413-13-005739.txt   4551832

Data Files

Seq Description Document Type Size
6 enz-20131031.xml EX-101.INS 651878
7 enz-20131031.xsd EX-101.SCH 47357
8 enz-20131031_cal.xml EX-101.CAL 35235
9 enz-20131031_def.xml EX-101.DEF 204538
10 enz-20131031_lab.xml EX-101.LAB 338418
11 enz-20131031_pre.xml EX-101.PRE 213955
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 131268833
SIC: 8071 Services-Medical Laboratories